The GINDEX® Growth Infusion International Index
The GINDEX® Growth Infusion International Index (GNDXI) is an applied market-cap weighted index measuring the performance of international companies that have previously acquired 100% Interest in a firm that has gone public through IPO, Direct Listing, and Spin-off in all world regions, except the United States (“IPO M&A”). The index utilizes a 10% cap on all constituents and is reconstituted and adjusted quarterly.